Iodine, Thyroid Function, and Cognition: Who Has Evidence of Benefit?

What the evidence shows

Randomized trials provide the clearest evidence of cognitive benefit in iodine-deficient schoolchildren, especially when deficiency is more pronounced.
Benefits in children were selective: some reasoning, processing, or visual tasks improved, while other memory and executive measures did not.
Pregnancy trials in mildly iodine-deficient women have not consistently improved children’s later IQ, executive function, language, or motor scores.
There is no established cognitive benefit for iodine supplementation in iodine-sufficient adults.
Higher iodine intake can alter thyroid physiology, so more is not automatically better.
The main research gaps are long-term outcomes, pregnancy timing, baseline thyroid status, and applicability to iodine-sufficient populations.

Why iodine status matters for the brain

Iodine is needed to produce thyroid hormones, and thyroid hormones are important for brain development. That biological link is strongest during fetal life, infancy, and childhood, when inadequate hormone production can affect neurodevelopment. It does not automatically mean that taking extra iodine improves cognition in people who already have adequate iodine status.

Human studies measure several different outcomes, and they should not be treated as interchangeable:

Urinary iodine indicates recent iodine intake at a population or individual level, but it is not a direct measure of cognitive function.
Thyroid markers such as thyroxine and thyroid-stimulating hormone show whether iodine status is influencing thyroid physiology.
Cognitive tests assess specific domains, such as perceptual reasoning, working memory, processing speed, language, or executive function.

The most credible evidence of benefit therefore comes from randomized trials in people who were iodine deficient at baseline and whose iodine status improved during the study.

Schoolchildren: the clearest evidence of cognitive benefit

The strongest direct evidence comes from randomized, placebo-controlled trials in iodine-deficient schoolchildren. In New Zealand, a double-blind trial enrolled 184 children aged 10 to 13 years with mild iodine deficiency. After 28 weeks, the iodine group performed better on two of four cognitive subtests, and the overall cognitive score was modestly higher. The improvement was concentrated in perceptual reasoning; working memory and symbol-search performance did not improve.

A separate double-blind trial in rural Albania studied 310 children aged 10 to 12 years with more substantial iodine deficiency. After 24 weeks, iodine status and thyroid measures improved, and the iodine group performed better on four of seven tests involving information processing, visual problem-solving, visual search, and fine motor skills.

These designs are stronger than observational comparisons because randomization and placebo control reduce the likelihood that socioeconomic status, diet, schooling, or baseline ability explains the group difference. However, the findings are not universal proof of a general cognitive-enhancement effect:

Participants were deficient schoolchildren, not healthy adults with established iodine sufficiency.
Benefits appeared in some cognitive domains but not others.
The trials were relatively short and did not establish durable effects on educational attainment or adult intelligence.
Results from iodine-deficient settings may not apply to populations with adequate iodine intake.

Pregnancy trials: biologically plausible, but controlled results are mostly null

Pregnancy is a major focus because fetal brain development depends on maternal thyroid hormone supply. Observational studies have often linked lower maternal iodine status with less favorable child-development measures, but associations can be affected by diet, education, socioeconomic conditions, thyroid disease, and other nutrients.

Randomized trials provide a more cautious picture. A double-blind trial in India and Thailand enrolled 832 mildly iodine-deficient pregnant women and followed their children to age 5 or 6 years. The children whose mothers received iodine did not have better verbal IQ, performance IQ, or parent-rated executive-function scores than children in the placebo group. Maternal iodine status improved, but the neurodevelopmental outcomes did not.

Another randomized trial was stopped after only 59 women had been enrolled. It found no meaningful difference in cognitive, language, or motor scores at 18 months, but its small size and early termination make it weak evidence for ruling benefit in or out.

Taken together, pregnancy supplementation has not yet shown a consistent cognitive advantage in adequately controlled trials of mildly deficient women. The results do not prove that iodine is unimportant in pregnancy; they show that correcting mild deficiency does not reliably translate into measurable improvements in later child testing under the conditions studied.

What systematic reviews add

The 2026 Cochrane review of iodine supplementation in children and adolescents included eight studies involving 2,528 participants, mainly in low-income settings and areas at risk of iodine deficiency. It concluded that supplementation produced a slight increase in cognitive function, but the cognitive comparison came from only one study involving 166 participants. Confidence in the broader evidence varied because the populations, interventions, follow-up periods, and study methods differed.

This matters because a pooled conclusion can sound broader than the underlying evidence. The review supports a small cognitive benefit in some deficient children, but it does not establish that iodine improves cognition across all ages or nutritional states. It also highlights that many studies were designed around iodine-deficiency disorders, thyroid outcomes, or growth rather than long-term cognitive performance.

A reasonable reading of the review is:

Evidence is most favorable when children begin with genuine iodine deficiency.
The expected effect is small and may be domain-specific.
Evidence quality is not strong enough to treat iodine as a general-purpose nootropic.
Long-term outcomes, including school achievement and adult functioning, remain inadequately studied.

Adults: thyroid effects are better studied than cognitive benefits

There is little reliable randomized evidence that iodine supplementation improves memory, attention, processing speed, or other cognitive outcomes in iodine-sufficient adults. Most adult trials examine iodine status or thyroid laboratory measures rather than validated cognitive endpoints.

A randomized, double-blind study of 256 euthyroid Chinese adults examined several iodine-intake levels over four weeks. Supplementation increased urinary iodine and thyroid-stimulating hormone; biochemical subclinical hypothyroidism appeared in some higher-intake groups. The study did not test cognition, so it cannot show that iodine harms mental performance, but it demonstrates that more iodine is not automatically physiologically neutral.

This distinction is important for interpreting supplement claims. A change in thyroid blood tests is not the same as improved cognition, and a biological rationale is not evidence of benefit. In adults without documented deficiency, the research base does not currently support a cognitive-enhancement conclusion.

Who appears most likely to benefit, and what remains uncertain

The best-supported population is iodine-deficient children, particularly schoolchildren living in settings where deficiency is moderate or severe and supplementation restores iodine and thyroid status. The New Zealand trial suggests that even mild deficiency may matter for some reasoning measures, but replication and generalizability remain limited.

The evidence is weaker for pregnant women with mild deficiency and their children. Controlled trials have not shown consistent improvements in childhood IQ or executive function. For iodine-sufficient adults, cognitive benefit remains unestablished, while thyroid responses to excess intake are documented.

Important unanswered questions include:

Which cognitive domains are most sensitive to iodine repletion?
Does timing during pregnancy, infancy, or childhood determine the size of any benefit?
Do improvements persist beyond the short follow-up periods used in many trials?
How do baseline thyroid status, iron status, diet, and socioeconomic conditions modify results?
What is the balance between correcting deficiency and provoking thyroid dysfunction in people who are already sufficient?

The evidence therefore supports iodine as an essential nutrient whose deficiency can matter for thyroid physiology and development, not as a broadly established cognitive enhancer.

Sources

About this article

NootroWorld publishes research summaries, not medical advice. This article describes what studies have and have not established; it does not tell you what to take. Supplements can interact with medication, pregnancy and existing health conditions, and study populations often differ from your own situation. Discuss any personal decision with a qualified healthcare professional.